Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort

American Journal of Gastroenterology

Volumn 107, Issue 4, 2012, Pages 589-596

  Eglinton, T W ^a,b   Roberts, R ^c   Pearson, J ^b   Barclay, M ^a,b   Merriman, T R ^c   Frizelle, F A ^a,b   Gearry, R B ^a,b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; IMMUNITY RELATED GUANOSINE TRIPHOSPHATASE PROTEIN TYPE M; NEUTROPHIL CYTOSOLIC FACTOR 4; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANUS DISEASE; ARTICLE; BREAST FEEDING; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; AGE FACTORS; ANUS DISEASES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NADPH OXIDASE; NEW ZEALAND; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84859620652     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.437     Document Type: Article

References (56)

1. Ardizzone S, Porro GB. Perianal Crohn's disease: overview. Dig Liver Dis 2007;39:957-8. (Pubitemid 47354990)
2. Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol 2009;3:513-34.
3. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29. (Pubitemid 34851835)
4. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6. (Pubitemid 32531409)
5. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. (Pubitemid 32531408)
6. Gearry RB, Roberts RL, Burt MJ et al. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis 2007;13:1220-7. (Pubitemid 47597768)
7. Franke A, McGovern DP, Barrett JC et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-25.
8. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008;8:458-66. (Pubitemid 351733422)
9. Klement E, Cohen RV, Boxman J et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 2004;80:1342-52.
10. Gearry RB, Richardson AK, Frampton CM et al. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010;25:325-33.
11. Gent AE, Hellier MD, Grace RH et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
12. Tang LY, Rawsthorne P, Bernstein CN et al. Are perineal and luminal fistulas associated in Crohn's disease? A population-based study. Clin Gastroenterol Hepatol 2006;4:1130-4. (Pubitemid 44311656)
13. Sachar DB, Bodian CA, Goldstein ES et al. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol 2005;100:1547-9. (Pubitemid 41032361)
14. Tarrant KM, Barclay ML, Frampton CMA et al. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol 2008;103:3082-93.
15. Eglinton T, Reilly M, Chang C et al. Ileal disease is associated with surgery for perianal disease in a population-based Crohn's disease cohort. Br J Surg 2010;97:1103-9.
16. Beaugerie L, Seksik P, Nion-Larmurier I et al. Predictors of Crohn's disease. Gastroenterology 2006;130:650-6. (Pubitemid 43374514)
17. Gearry RB, Richardson A, Frampton CM et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 2006;12:936-43. (Pubitemid 44498282)
18. Subnational Population Statistics. In: Statistics New Zealand, 2005. Available at: http://www.stats.govt.nz. Accessed March 15, 2006.
19. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6; discussion 16- 19.
20. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 (Suppl A):5-36.
21. American Gastroenterological Association Clinical Practice C. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003;125:1503-7.
22. Roberts RL, Gearry RB, Barclay ML et al. Rapid detection of common CARD15 variants in patients with inflammatory bowel disease. Mol Diagn 2004;8:101-5. (Pubitemid 39363464)
23. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing 2010.
24. Little J, Higgins JP, Ioannidis JP et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol 2009;24:37-55.
25. Williams DR, Coller JA, Corman ML et al. Anal complications in Crohn's disease. Dis Colon Rectum 1981;24:22-4. (Pubitemid 11150985)
26. Rankin GB, Watts HD, Melnyk CS et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77:914-20. (Pubitemid 9242053)
27. Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis 1986;1:104-7. (Pubitemid 18004475)
28. Veloso FT, Ferreira JT, Barros L et al. Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity. Inflamm Bowel Dis 2001;7:306-13.
29. Lockhart-Mummery HE. Symposium. Crohn's disease: anal lesions. Dis Colon Rectum 1975;18:200-2.
30. Fielding JF. Perianal lesions in Crohn's disease. J R Coll Surg Edinb 1972;17:32-7.
31. Platell C, Mackay J, Collopy B et al. Anal pathology in patients with Crohn's disease. Aust NZ J Surg 1996;66:5-9. (Pubitemid 126422502)
32. Eglinton TW, Gearry RB. Clinical factors predicting disease course in Crohn's disease. Expert Rev Clin Immunol 2010;6:41-5.
33. Schwartz DA, Loft us Jr EV, Tremaine WJ et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroentero logy 2002;122:875-80.
34. Lapidus A, Lapidus A. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update [see comment]. World J Gastroenterol 2006;12:75-81. (Pubitemid 43126087)
35. Halme L, Sainio AP. Factors related to frequency, type, and outcome of anal fistulas in Crohn's disease. Dis Colon Rectum 1995;38:55-9.
36. Roberts PL, Schoetz DJ, Pricolo Jr R et al. Clinical course of Crohn's disease in older patients. A retrospective study. Dis Colon Rectum 1990;33:458-62. (Pubitemid 20187503)
37. Cosnes J, Cattan S, Blain A et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50. (Pubitemid 34784976)
38. Hellers G, Bergstrand O, Ewerth S et al. Occurrence and outcome aft er primary treatment of anal fistulae in Crohn's disease. Gut 1980;21 : 525-7. (Pubitemid 10059414)
39. Smith BR, Arnott ID, Drummond HE et al. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease. Inflamm Bowel Dis 2004;10:521-8. (Pubitemid 39276458)
40. Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-62.
41. Glas J, Seiderer J, Pasciuto G et al. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population. Am J Gastroenterol 2009;104:665-72.
42. Amre DK, Mack DR, Israel D et al. NELL1, NCF4, and FAM92B genes are not major susceptibility genes for Crohn's disease in Canadian children and young adults. Inflamm Bowel Dis 2011.
43. Matute JD, Arias AA, Dinauer MC et al. p40phox: the last NADPH oxidase subunit. Blood Cells Mol Dis 2005;35:291-302. (Pubitemid 41267062)
44. Ellson CD, Davidson K, Ferguson GJ et al. Neutrophils from p40phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J Exp Med 2006;203:1927-37. (Pubitemid 44188467)
45. Roberts RL, Hollis-Moffatt JE, Gearry RB et al. Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun 2008;9:561-5.
46. Armuzzi A, Ahmad T, Ling KL et al. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 2003;52:1133-9. (Pubitemid 36877425)
47. Vermeire S, Pierik M, Hlavaty T et al. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology 2005;129:1845-53. (Pubitemid 41772963)
48. Palmieri O, Latiano A, Valvano R et al. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2006;23:497-506. (Pubitemid 43382004)
49. Onnie CM, Fisher SA, Prescott NJ et al. Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease. Eur J Gastroenterol Hepatol 2008;20:37-45. (Pubitemid 350307487)
50. Newman B, Gu X, Wintle R et al. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 2005;128:260-9. (Pubitemid 40431079)
51. Karban A, Itay M, Davidovich O et al. Risk factors for perianal Crohn's disease: the role of genotype, phenotype, and ethnicity. Am J Gastroenterol 2007;102:1702-8. (Pubitemid 47206693)
52. Parkes M, Barrett JC, Prescott NJ et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007;39:830-2. (Pubitemid 47014496)
53. Latiano A, Palmieri O, Cucchiara S et al. Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol 2009;104:110-6.
54. Han Z, Li C, Han S et al. Meta-analysis: polymorphisms in TNF-alpha gene promoter and Crohn's disease. Aliment Pharmacol Ther 2010;32:159-70.
55. Kim TH, Kim BG, Shin HD et al. [Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease]. Korean J Gastroenterol 2003;42:377-86.
56. Baert F, Caprilli R, Angelucci E. Medical therapy for Crohn's disease: top-down or step-up? Dig Dis 2007;25:260-6. (Pubitemid 350194180)